Study S002388

Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome: A Prospective Comparative Randomized Blinded Trial.

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06576375
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: QUADRUPLE
Status: UNKNOWN
Enrollment: 70
Start: 2024-09-02
Primary completion: 2025-01
Lead sponsor: Future University in Egypt
Conditions: Polycystic Ovary Syndrome
Interventions: DRUG:Dapagliflozin; DRUG:Metformin
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Fertility parameters- Luteinizing hormone [3-6 months]
Fertility parameters-Follicle-stimulating hormone [3-6 months]
Fertility parameters-Free androgen index [3-6 months]
Fertility parameters-Total testosterone [3-6 months]
Transvaginal ultrasonography [3-6 months]
Menstrual diaries [3-6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.